Education
About Us
Working with TipRanks
Follow Us
Resmed (RMD)
NYSE:RMD
Earnings Data
Report Date
Jul 31, 2025TBA Not Confirmed
Period Ending
2025 (Q4)Consensus EPS Forecast
2.48Last Year’s EPS
2.08Same Quarter Last Year
Moderate Buy
Based on 14 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Apr 23, 2025
|% Change Since: 10.87%
|Next Earnings Date:Jul 31, 2025
Earnings Call Sentiment|Positive
The earnings call highlighted strong revenue growth, gross margin expansion, successful product launches, and increased share buybacks. Despite challenges such as sleep lab backlogs and foreign currency impacts, ResMed demonstrated resilience with strategic expansions and maintaining tariff exemptions.Company Guidance
During the Q3 Fiscal Year 2025 earnings call, ResMed reported strong financial performance, highlighting several key metrics. The company achieved a revenue of $1.29 billion, marking an 8% increase year-over-year, or 9% in constant currency terms. Gross margin expanded by 140 basis points to 59.9%, driven by manufacturing and logistics efficiencies and favorable product mix shifts. Sales in the US, Canada, and Latin America increased by 9%, while sales in Europe, Asia, and other regions grew by 8% on a constant currency basis. ResMed's SG&A expenses improved slightly as a percentage of revenue to 19%, while R&D expenses were 6.5% of revenue. The company generated strong free cash flow of $579 million, including a tax refund, and ended the quarter with a cash balance of $933 million. ResMed plans to increase its share buyback program to $100 million per quarter, reflecting confidence in its financial position despite ongoing global uncertainties.Strong Revenue Growth
Group revenue for Q3 FY2025 was $1.29 billion, an 8% headline increase and 9% in constant currency terms. Device sales increased by 7% globally, while masks and other sales increased by 12% in constant currency.
Gross Margin Expansion
Gross margin increased by 140 basis points to 59.9% in the March quarter, driven by manufacturing and logistics efficiencies and favorable product mix shifts.
Successful Launch of New Products
The first full commercial rollout of Nite Owl and the launch of AirSense 11 version of VPAP Tx contributed to new technology introductions to customers in Q3.
Recognition for Innovation
ResMed was named in the Lexus Nexus list of the top 100 global innovators, showcasing the company's market-leading efforts in pioneering innovation.
Strong Cash Flow and Net Income
Cash flow from operations was $579 million, and net income for the March quarter increased by 11%, with non-GAAP diluted earnings per share of $2.37, also increasing by 11%.
Expansion of Manufacturing Facilities
ResMed is opening a new advanced manufacturing facility in Calabasas, California, which will almost double its manufacturing footprint in the US.
Increased Share Buyback Program
ResMed plans to increase its ongoing share buyback program to purchase shares to the value of approximately $100 million per quarter starting in Q4 FY2025.
Tariff Exemptions Maintained
ResMed confirmed that it will continue to benefit from tariff exemptions on its products imported into the US, mitigating potential impacts from new tariffs.
---
RMD Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
RMD Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Apr 23, 2025 | $214.44 | $236.10 | +10.10% |
| Jan 30, 2025 | $257.07 | $235.65 | -8.33% |
| Oct 24, 2024 | $238.00 | $254.94 | +7.12% |
| Aug 01, 2024 | $213.11 | $222.13 | +4.23% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Resmed (RMD) report earnings?
Resmed (RMD) is schdueled to report earning on Jul 31, 2025, TBA Not Confirmed.
What is Resmed (RMD) earnings time?
Resmed (RMD) earnings time is at Jul 31, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is RMD EPS forecast?
RMD EPS forecast for the fiscal quarter 2025 (Q4) is 2.48.
---